Abstract
Several small studies have suggested that bone marrow mononuclear cell (BMC) therapy for ischemic cardiomyopathy is safe. However, none of these
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
